Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Aptinyx Yönetim

Yönetim kriter kontrolleri 1/4

We currently do not have sufficient information about the CEO.

Anahtar bilgiler

Craig Jalbert

İcra Kurulu Başkanı

n/a

Toplam tazminat

CEO maaş yüzdesin/a
CEO görev süresiless than a year
CEO sahipliğin/a
Yönetim ortalama görev süresi2.6yrs
Yönetim Kurulu ortalama görev süresi1.9yrs

Son yönetim güncellemeleri

Recent updates

Aptinyx musculoskeletal pain drug NYX-2925 fails mid-stage study

Aug 12

We're Keeping An Eye On Aptinyx's (NASDAQ:APTX) Cash Burn Rate

Aug 18
We're Keeping An Eye On Aptinyx's (NASDAQ:APTX) Cash Burn Rate

Aptinyx: CNS Drug Discoverer With Depressed Price

Jul 21

Aptinyx updates on mid-stage clinical program for PTSD therapy

Jun 15

Aptinyx (NASDAQ:APTX) Is In A Good Position To Deliver On Growth Plans

Apr 13
Aptinyx (NASDAQ:APTX) Is In A Good Position To Deliver On Growth Plans

Did You Miss Aptinyx's (NASDAQ:APTX) 15% Share Price Gain?

Mar 09
Did You Miss Aptinyx's (NASDAQ:APTX) 15% Share Price Gain?

What Kind Of Shareholders Hold The Majority In Aptinyx Inc.'s (NASDAQ:APTX) Shares?

Jan 30
What Kind Of Shareholders Hold The Majority In Aptinyx Inc.'s (NASDAQ:APTX) Shares?

Aptinyx recommences Phase 2 study of NYX-2925

Jan 04

Have Insiders Been Buying Aptinyx Inc. (NASDAQ:APTX) Shares This Year?

Dec 26
Have Insiders Been Buying Aptinyx Inc. (NASDAQ:APTX) Shares This Year?

What Type Of Returns Would Aptinyx's(NASDAQ:APTX) Shareholders Have Earned If They Purchased Their SharesYear Ago?

Nov 27
What Type Of Returns Would Aptinyx's(NASDAQ:APTX) Shareholders Have Earned If They Purchased Their SharesYear Ago?

CEO

Craig Jalbert (61 yo)

less than a year

Görev süresi

Mr. Craig R. Jalbert, CIRA, serves as President, Corporate Secretary, Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer at Evelo Biosciences, Inc. since November 21,...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Craig Jalbert
Principal Executive Officerless than a yearVeri yokVeri yok
Patrick Flavin
Senior Manager of Corporate Development & Investor Relationsno dataVeri yokVeri yok
Molly Dir
Vice President of Human Resources2.6yrsVeri yokVeri yok
Kathryn King
Senior Vice President of Clinical & CMC Operations5yrsVeri yokVeri yok
Tim Noffke
VP of Program Management & Chief of Staff1.7yrsVeri yokVeri yok
Harald Murck
Vice President of Clinical & Medical Affairs3yrsVeri yokVeri yok

2.6yrs

Ortalama Görev Süresi

Deneyimli Yönetim: APTX's management team is considered experienced (2.6 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Craig Jalbert
Principal Executive Officerless than a yearVeri yokVeri yok
Peter LeWitt
Member of Scientific Advisory Board1.9yrsVeri yokVeri yok
Gerard Sanacora
Member of Scientific Advisory Board1.9yrsVeri yokVeri yok
Lesley Arnold
Member of Scientific Advisory Board1.9yrsVeri yokVeri yok
Chadi Abdallah
Member of Scientific Advisory Board1.9yrsVeri yokVeri yok

1.9yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: APTX's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.